Ohio: Once pegged as a blockbuster medicine for lowering LDL, long-acting small interfering RNA, Inclisiran failed to find ...

The clinical and financial implications of inpatient dermatology were examined, highlighting the need for systemic changes to ...

At the heart of the crisis lies the Social Health Insurance Authority's (Shia) failure to recognise facilities and practitioners registered under the Clinical Officers Council.

A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...

Recognizing psoriasis and psoriatic arthritis (PsA) in non-White patients is the first step toward providing more equitable care for those of all backgrounds with PsA, according to Rebecca Haberman, ...

Noninvasive monitoring methods, such as enterography and ultrasound, are becoming increasingly recognized as essential tools ...

Semaglutide is a GLP-1 agonist that works by reducing appetite, delaying gastric emptying, increasing insulin release, and lowering the amount of glucagon released. Semaglutide is a glucagon-like ...

Despite continuous advances in medical research, the implementation of evidence-based changes within the healthcare system is ...